SightfileU.S. market data from official filings

LONGEVERON INC (LGVN)

Name: LONGEVERON INC (LGVN) — Institutional ownership, SEC filings and insider activity
Creator: Sightfile
License: https://www.sec.gov/privacy#dissemination

Institutional ownership, SEC filings and insider activity

Sector: Healthcare & Pharma · SEC CIK 0001721484 · EDGAR filings · Updated 2026-07-21

LONGEVERON INC (LGVN) has 31 institutional managers reporting positions valued at $2.37M per the latest 13F reporting period. SEC filings include an active notice of delisting or failure to satisfy a continued listing rule (8-K Item 3.01), substantial-doubt (going concern) disclosure per the filings.

Institutional managers

Reported 13F value

$2.37M

Insider activity

43 trans.

−$36.7K net selling

Data flags

2 active

from SEC filings

Latest updates

2026-07-21 — Initial insider ownership filed (Form 3)
2026-07-14 — Initial insider ownership filed (Form 3)
2026-07-14 — Current report (8-K) filed
2026-07-13 — Initial insider ownership filed (Form 3)
2026-07-13 — Initial insider ownership filed (Form 3)
2026-07-10 — Employee-plan registration (S-8) filed

Institutional ownership overview

According to SEC 13F filings tracked by Sightfile, LONGEVERON INC has 31 institutional holders.

Insider activity

Insiders reported 43 transactions (2 buys, 4 sells) across 15 reporting insiders, with a net reported value of −$36.7K.

Data flags from SEC filings

Active substantial-doubt (going concern) disclosure per the filings, most recently filed 2026-05-13 (recurring since 2023-05-12) — source filing. The authoritative details are those stated in the filing itself.

Active notice of delisting or failure to satisfy a continued listing rule (8-K Item 3.01), most recently filed 2026-03-25 (recurring since 2024-03-07) — source filing. The authoritative details are those stated in the filing itself.

Related companies

Bolt Biotherapeutics Inc (BOLT) · BIOATLA INC (BCAB) · CEL SCI Corp (CVM) · MIRA PHARMACEUTICALS INC COM (MIRA) · IMPACT BIOMEDICAL INC (IBO) · Outlook Therapeutics Inc (OTLK)

See full history, cross-references and alerts on Sightfile

Sightfile provides information only — not investment advice, recommendations, or an assessment of any security. Data is derived from official public sources (SEC EDGAR and U.S. government agencies), may contain errors or delays, and should be verified against the source filing before relying on it.
Data sources: SEC EDGAR (filings, 13F, FTD), aggregated by Sightfile. Page updated 2026-07-21.